Home/Industry Insights

Industry Insights

Deep dives on clinical endpoints, regulatory trends and data quality — written and curated by the EClinCloud team.

Insights Deep Research Newsroom Clear filter

Oncology Evidence & Study Operations — EClinCloud editorial cover

Deep Research2026-10-3035 min readOncology Trial Evidence: Survival, Combination Effects and Study OperationsConnect FDA oncology guidance on survival, component contribution, radiopharmaceutical safety, biopsies and patient outcomes to traceable study operations.

ICH E20 & Bayesian Trial Architecture — EClinCloud editorial cover

Deep Research2026-10-2848 min readAdaptive and Bayesian Trials: From Statistical Design to Controlled OperationsConnect adaptive and Bayesian trial guidance to justified simulation, independent monitoring, controlled data handoffs and reproducible study operations.

BIMO request-response paths — EClinCloud editorial cover

Deep Research2026-10-269 min readBIMO Inspection or Remote Assessment? Build the Response Around the Actual Request (2026)Classify BIMO inspections, mandatory requests and voluntary remote assessments, then route the actual deadline, access scope and response evidence to an owner.

CGM and immunogenicity data — EClinCloud editorial cover

Deep Research2026-10-2411 min readFDA's 2026 CGM and Immunogenicity-PK Specifications: Preserve the Path from Source to AnalysisDistinguish source observations, missing records and analysis derivations when implementing FDA’s 2026 CGM and immunogenicity-PK dataset recommendations.

COA evidence and eCOA release — EClinCloud editorial cover

Deep Research2026-10-227 min readCOA Qualification and eCOA Release: Keep the Evidence Status Attached to the Instrument (2026)Separate COA qualification, submissions and Compendium evidence, then preserve the instrument’s context of use, version and permission in an eCOA release.

Rare-disease re-enrollment — EClinCloud editorial cover

Deep Research2026-10-2010 min readFDA Participation Guidance: Build a Distinct Handoff for Rare-Disease Re-Enrollment (2026)Turn FDA’s rare-disease re-enrollment recommendation into a protocol-specific handoff while preserving prior exposure, selection-bias and authorized-access limits.

Collection groups and observation periods for ICH E19 safety data design

Deep Research2026-10-0633 min readICH E19 Safety Data Collection in 2026: CRF Scope and Analysis DenominatorsCompare ICH E19 collection classes, four implementation examples, regional exceptions and trial-specific laboratory schedules before configuring the CRF and analysis plan.

Your first trial module map — EClinCloud research cover

Deep Research2026-09-1858 min readHow Many Systems Does Your First Trial Need? A Registry-Derived eClinical Module Map for Small Sponsors (2026)A protocol-based guide to the records, workflows and eClinical capabilities needed for a first regulated clinical trial.